In a major victory for public health, a three-judge panel of the U.S. Court of Appeals for the Fifth Circuit has unanimously upheld graphic health warnings on cigarette packs and advertising required under a 2020 FDA rule.
WASHINGTON, D.C.— March 21, 2024 — Today, Congress released a series of spending bills aimed to finalize FY2024 funding that includes a $300 million increase in funding for the National Health Institute (NIH) base budget, including a $120 million increase in discretionary funding for the National Cancer Institute (NCI), a modest $500,000 increase for the Centers for Disease Control and Prevention (CDC) cancer screening and prevention programs and maintains the current funding level for the Advanced Research Projects Agency for Health (ARPA-H) at $1.5 billion.
Today, the American Cancer Society Cancer Action Network submitted a statement for the record to the House Energy & Commerce Committee Health Subcommittee in regards to their hearing on Evaluating Approaches to Diagnostic Test Regulation and the impact of the FDA’s proposed rule.
As one of the leading patient advocacy groups that advocated for the passage of the Affordable Care Act (ACA), the American Cancer Society Cancer Action Network (ACS CAN) is celebrating the impact of the historic law ahead of its 14th anniversary on Saturday. ACS CAN is marking the milestone by urging Congress, state lawmakers and the U.S. Court of Appeals for the Fifth Circuit to protect and strengthen the critical patient protections of the ACA.
The House Energy and Commerce Committee’s Subcommittee on Health today marked up the Screening for Communities to Receive Early and Equitable Needed Services (SCREENS) for Cancer Act, H.R. 3916. The bipartisan legislation would reauthorize the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) through 2028.
The American Cancer Society Cancer Action Network (ACS CAN) is pleased to see President Biden’s continued focus on and dedication to achieving the goal of the Cancer Moonshot to end cancer as we know it, for everyone.
The Biden Cancer Moonshot announced today the expansion of coverage for patient navigation services in plans from seven health insurance companies.
WASHINGTON, D.C.— March 7, 2024 —Ahead of President Biden’s State of the Union Address, the American Cancer Society Cancer Action Network (ACS CAN) is calling on the president to emphasize the need for continued bipartisan support for increased federal investment for cancer research at the National Institutes of Health (NIH) and National Cancer Institute (NCI) as well as prevention program funding at the Centers for Disease Control and Prevention (CDC). Additionally, ACS CAN is urging the president to finalize the Food and Drug Administration’s rule prohibiting the sale of menthol in cigarettes without delay.
Milwaukee attorney Philip R. O’Brien has accepted the role of Cancer Votes National Ambassador for the American Cancer Society Cancer Action Network (ACS CAN), the advocacy affiliate of the American Cancer Society (ACS). This role is an expansion of O’Brien’s current commitment to ACS CAN as a member of its national Board of Directors since 2019. Cancer Votes is ACS CAN’s nonpartisan electoral program, a public education avenue through which cancer issues are elevated as a key priority during election cycles. As National Ambassador, Phil O’Brien will serve as a brand leader, seeking to draw high levels of engagement from volunteers, the media and the advocacy and business communities.
Today, the U.S. Court of Appeals for the Fifth Circuit will hear oral arguments in Braidwood Management v. Becerra, a case that threatens access to evidence-based preventive services without cost-sharing as required under the Affordable Care Act (ACA). The services at-risk include those recommended by scientific experts at the U.S. Preventive Services Task Force (USPSTF), the Advisory Committee on Immunization Practices (ACIP) and the Health Resources and Services Administration (HRSA).